Table 2 Risk for Behçet’s disease according to HDL-C.

From: Risk for Behçet’s disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea

 

Events (n)

Follow-up duration (person-years)

Incidence rate *

HRs (95% CIs)

Model 1

Model 2

Model 3

High mean/low variability

214

5,791,230.82

0.03695

1 (reference)

1 (reference)

1 (reference)

High mean/high variability

172

5,798,263.77

0.02966

1.248 (0.990–1.574)

1.334 (1.057–1.683)

1.335 (1.058–1.684)

Low mean/low variability

161

5,785,043.13

0.02783

1.350 (1.074–1.697)

1.526 (1.210–1.923)

1.527 (1.211–1.925)

Low mean/high variability

129

5,753,333.91

0.02242

1.719 (1.378–2.144)

2.094 (1.669–2.628)

2.096 (1.670–2.630)

  1. Model 1: adjusted for age, sex, alcohol use, smoking, exercise, and income. Model 2: adjusted for model 1 plus body mass index, diabetes mellitus, and hypertension. Model 3: adjusted for model 2 plus mean HDL-C. The low mean group includes participants in the first quartile of mean HDL-C (men: < 44.7 mg/dL, women: < 51.7 mg/dL), the high mean group includes those in the second to fourth quartiles, the low variability group includes the first to third quartiles of HDL-C variability, and the high variability group includes the fourth quartile (men: ≥ 10.4%, women: ≥ 8.5%).
  2. CI confidence interval, HDL-C high-density lipoprotein cholesterol, HR hazard ratio, VIM variability independent of the mean.
  3. *Per 1000 person-years.
Back to article page